HAG
GSK icon

HF Advisory Group’s GSK GSK Stock Holding History

HF Advisory Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$397K Buy
7,578
+259
+4% +$13.7K 0.12% 143
2026
Q1 		$404K Sell
7,319
-1,327
-15% -$71.9K 0.14% 130
2025
Q4 		$424K Sell
8,646
-912
-10% -$42.5K 0.15% 135
2025
Q3 		$413K Buy
9,558
+204
+2% +$7.97K 0.15% 134
2025
Q2 		$359K Sell
9,354
-401
-4% -$15.3K 0.14% 134
2025
Q1 		$378K Buy
9,755
+1,012
+12% +$37K 0.17% 130
2024
Q4 		$296K Buy
8,743
+990
+13% +$35.6K 0.14% 136
2024
Q3 		$317K Sell
7,753
-717
-8% -$29.3K 0.15% 135
2024
Q2 		$326K Buy
8,470
+405
+5% +$17K 0.17% 134
2024
Q1 		$346K Sell
8,065
-462
-5% -$19.1K 0.19% 131
2023
Q4 		$316K Sell
8,527
-179
-2% -$6.43K 0.2% 131
2023
Q3 		$315K Buy
8,706
+201
+2% +$7.13K 0.23% 122
2023
Q2 		$303K Buy
8,505
+369
+5% +$13.2K 0.24% 114
2023
Q1 		$289K Buy
8,136
+674
+9% +$23.6K 0.26% 113
2022
Q4 		$262K Buy
+7,462
New +$249K 0.27% 114

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

HF Advisory Group's GSK Position: Q2 2026 in Review

HF Advisory Group increased its GSK (GSK) stake by 3.5% in Q2 2026, buying an estimated $13.7K and bringing the position to 7,578 shares worth $397K. The position accounts for 0.12% of the portfolio, ranked #143.

HF Advisory Group first reported a position in GSK in Q4 2022 and has held it in 15 quarters since. The position peaked at $424K in Q4 2025. 241 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • HF Advisory Group held 7,578 shares of GSK worth $397K as of Q2 2026.
  • HF Advisory Group bought 259 GSK shares in Q2 2026, an estimated $13.7K.
  • GSK made up 0.12% of HF Advisory Group's portfolio in Q2 2026, its #143 holding.
  • HF Advisory Group first reported a position in GSK in Q4 2022 and has held it in 15 quarters since.
  • HF Advisory Group's GSK position peaked at $424K in Q4 2025.
  • 241 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on HF Advisory Group's 13F filing for Q2 2026, filed 9 Jul 2026.